Prevalence, birth incidence, and penetrance of von Hippel-Lindau disease (vHL) in Denmark.

Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med (2002) 6.94

Von Hippel-Lindau disease: a genetic study. J Med Genet (1991) 3.61

Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus. Lancet (1991) 3.10

von Hippel-Lindau disease: a clinical and scientific review. Eur J Hum Genet (2011) 2.45

Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A (2010) 2.05

A genetic register for von Hippel-Lindau disease. J Med Genet (1996) 1.61

Genetic analysis of von Hippel-Lindau disease. Hum Mutat (2010) 1.55

Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect. Hum Genet (1995) 1.42

Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents. Am J Hum Genet (2000) 1.33

Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene. Hum Mol Genet (1995) 1.25

The genetics of phaeochromocytoma: using clinical features to guide genetic testing. Eur J Endocrinol (2011) 1.22

Life expectancy in hereditary cancer predisposing diseases: an observational study. J Med Genet (2012) 1.20

Germline mutations in the von Hippel-Lindau (VHL) gene in patients from Poland: disease presentation in patients with deletions of the entire VHL gene. J Med Genet (2002) 1.07

Frequency of Von Hippel-Lindau germline mutations in classic and non-classic Von Hippel-Lindau disease identified by DNA sequencing, Southern blot analysis and multiplex ligation-dependent probe amplification. Clin Genet (2007) 1.02

VHL c.505 T>C mutation confers a high age related penetrance but no increased overall mortality. J Med Genet (2001) 1.01

Surveillance in von Hippel-Lindau disease (vHL). Clin Genet (2009) 0.96

Identification of 3 novel VHL germ-line mutations in Danish VHL patients. BMC Med Genet (2012) 0.93

Genetics of familial renal cancers. Nephron Exp Nephrol (2010) 0.92

The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system. J Neurol Neurosurg Psychiatry (1999) 0.92

Von Hippel-Lindau disease (vHL). National clinical guideline for diagnosis and surveillance in Denmark. 3rd edition. Dan Med J (2013) 0.88

Von Hippel-Lindau disease germline mutations in Mexican patients with cerebellar hemangioblastoma. J Neurosurg (2006) 0.83

Risk of new tumors in von Hippel-Lindau patients depends on age and genotype. Genet Med (2015) 0.75

Management of Gene Variants of Unknown Significance: Analysis Method and Risk Assessment of the VHL Mutation p.P81S (c.241C>T). Curr Genomics (2017) 0.75

von Hippel-Lindau development in children and adolescents. Am J Med Genet A (2017) 0.75

Survival and causes of death in patients with von Hippel-Lindau disease. J Med Genet (2016) 0.75

Retinal hemangioblastoma: prevalence, incidence and frequency of underlying von Hippel-Lindau disease. Br J Ophthalmol (2017) 0.75